Company Performance Metrics
Our mission is enabling solutions for the global problem of substandard and falsified (SF) drugs.
The ARTiFACTS Verify SaaS platform contributes to reducing the incidence of Substandard and Falsified (SF) prescription pharmaceutical products in the supply chain by integrating systematic screening of the ingredients contained in medicines with
chain-of-custody and secured provenance of all scientific and operational data:
• SF medicines are a $30 billion financial problem for stakeholders – in addition to the health and safety risks for patients and trustworthiness of the pharma supply chain;
• ARTiFACTS has completed a successful pilot with the University of Notre Dame which is deploying Verify in production use across its international network;
• We have invested $1.4 million in its development and are now seeking capital to support the commercial expansion of Verify.
Verify is a cloud-based information management system that provides fast, trusted and transparent targeted intelligence that regulatory authorities and other stakeholders rely on to remove SF products and their suppliers from the market. High-volume processing of medicine samples, accurate and trusted results for mitigation actions by stakeholder organizations are the primary benefits of Verify.
Verify is unique in integrating scientific and operational supply chain data to address the global problem of SF drugs:
• Scientists and researchers use Verify as a distributed laboratory notebook to capture, analyze, secure and report data findings;
• Commercial and non-profit clients use Verify to detect, intervene and remove SF drugs from the market.
